Patent · US Active

Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)

US9458239B2 · kind B2 · utility

2Cited by

1References

19Claims

0Family size

Assignee

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Isabelle Teulon · Bagnols-sur-Cèze, FR
Andre Pelegrin · Montpellier, FR

Key dates

Filing date	Sep 5, 2012
Grant date	Oct 4, 2016
Priority date	—
Expiry date	Oct 11, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.